Navigation Links
Scientists decipher genome of fungus that can cause life-threatening infections

In a project that already has benefited an important field of biomedical research, scientists have deciphered the genomes of two closely related strains of Cryptococcus neoformans, a fungus whose importance as a human pathogen has risen in parallel with the HIV/AIDS worldwide epidemic and the increased use of immunosuppressive therapies. The study, posted online January 13 in Science Express, revealed differences in the virulence strategies used by C. neoformans compared to other pathogenic fungi. Researchers also examined the genetic determinants of its pathogenicity by comparing the genomes of two closely related strains of significantly different virulence.

"Not only have we established a genomic platform for the further study of this increasingly important pathogen, but the data from the two strains may provide insight into what determines virulence," says Brendan Loftus, a scientist at The Institute for Genomic Research (TIGR) who is the first author of the Science paper. "Although the two Cryptococcus strains we examined differ significantly in virulence, we found surprisingly little difference in their gene content." TIGR scientists led by primary investigator Claire M. Fraser, the President of TIGR, deciphered the genome of one strain of C. neoformans while researchers led by Richard Hyman at Stanford University's Genome Technology Center in Palo Alto, CA, sequenced the second strain. The project was funded by the National Institute of Allergy and Infectious Diseases (NIAID), part of the National Institutes of Health. Numerous collaborators helped to interpret and analyze the genome sequence data. C. neoformans, an oval-shaped yeast, is an opportunistic human pathogen of global importance that is used by researchers as a model for fungal pathogenesis. Since the 1980s, the number of Cryptococcus infections has increased sharply ?mainly among people with impaired immunity, including those who have HIV/AIDS or who receive cancer chemotherapy, steroid tre
'"/>

Source:TIGR


Page: 1 2 3 4

Related biology news :

1. Scientists ID molecular switch in liver that triggers harmful effects of saturated and trans fats
2. Scientists Replicate Hepatitis C Virus in Laboratory
3. Scientists detect probable genetic cause of some Parkinsons disease cases
4. Scientists find missing enzyme for tuberculosis iron scavenging pathway
5. Scientists seek answers on what activates deadly anthrax spores
6. Yale Scientists Find MicroRNA Regulates Ras Cancer Gene
7. Scientists collaborate to assess health of global environment
8. Scientists discover the cellular roots of graying hair
9. Scientists rid stem cell culture of key animal cells
10. Scientists develop new color-coded test for protein folding
11. Scientists identify genetic pathways essential to RNA interference

Post Your Comments:
(Date:11/4/2009)...ct. 20 Quest Diagnostics...rovider of diagnostic testing, information and ser...September 30, 2009, income from continuing operati...re, from $160 million, or $0.81 per diluted share,...rter results were reduced by a $0.03 per share cha...
(Date:11/4/2009)... 26 BIO-key Internationa...nger-based biometric identification software is sh...he AABB TXPO conference being held at the New Orle...-key will provide hands-on product demonstrations ...in booth #424. Also, at 5 PM on Monday, October 26...
(Date:11/3/2009)...ER 4, 2009 -- The world,s greatest wines are the ... human input, and something called the "terroir" -... and climate. , Experts will discuss terroir w...Wednesday, Nov. 4 in Pittsburgh. "Terroir: Winegr... parts at the 2009 Annual Meetings of the American...
Breaking Biology News(10 mins):Quest Diagnostics Reports Strong Performance in Third Quarter 2009 2Quest Diagnostics Reports Strong Performance in Third Quarter 2009 3Quest Diagnostics Reports Strong Performance in Third Quarter 2009 4Quest Diagnostics Reports Strong Performance in Third Quarter 2009 5Quest Diagnostics Reports Strong Performance in Third Quarter 2009 6Quest Diagnostics Reports Strong Performance in Third Quarter 2009 7Quest Diagnostics Reports Strong Performance in Third Quarter 2009 8Quest Diagnostics Reports Strong Performance in Third Quarter 2009 9Quest Diagnostics Reports Strong Performance in Third Quarter 2009 10Quest Diagnostics Reports Strong Performance in Third Quarter 2009 11Quest Diagnostics Reports Strong Performance in Third Quarter 2009 12Quest Diagnostics Reports Strong Performance in Third Quarter 2009 13Quest Diagnostics Reports Strong Performance in Third Quarter 2009 14Quest Diagnostics Reports Strong Performance in Third Quarter 2009 15Quest Diagnostics Reports Strong Performance in Third Quarter 2009 16Quest Diagnostics Reports Strong Performance in Third Quarter 2009 17BIO-key(R) International Exhibiting at AABB TXPO 2Great wines come from great soils 2AMICAS Reports Financial Results for the Second Quarter Ended June 30 2009 53787 1AMICAS Reports Financial Results for the Second Quarter Ended June 30 2009 53787 2AMICAS Reports Financial Results for the Second Quarter Ended June 30 2009 53787 3AMICAS Reports Financial Results for the Second Quarter Ended June 30 2009 53787 4AMICAS Reports Financial Results for the Second Quarter Ended June 30 2009 53787 5AMICAS Reports Financial Results for the Second Quarter Ended June 30 2009 53787 6AMICAS Reports Financial Results for the Second Quarter Ended June 30 2009 53787 7AMICAS Reports Financial Results for the Second Quarter Ended June 30 2009 53787 8AMICAS Reports Financial Results for the Second Quarter Ended June 30 2009 53787 9AMICAS Reports Financial Results for the Second Quarter Ended June 30 2009 53787 10AMICAS Reports Financial Results for the Second Quarter Ended June 30 2009 53787 11AMICAS Reports Financial Results for the Second Quarter Ended June 30 2009 53787 12AMICAS Reports Financial Results for the Second Quarter Ended June 30 2009 53787 13AMICAS Reports Financial Results for the Second Quarter Ended June 30 2009 53787 14AMICAS Reports Financial Results for the Second Quarter Ended June 30 2009 53787 15AMICAS Reports Financial Results for the Second Quarter Ended June 30 2009 53787 16AMICAS Reports Financial Results for the Second Quarter Ended June 30 2009 53787 17MedCath Corporation Reports Third Quarter Earnings 53784 1MedCath Corporation Reports Third Quarter Earnings 53784 2MedCath Corporation Reports Third Quarter Earnings 53784 3MedCath Corporation Reports Third Quarter Earnings 53784 4MedCath Corporation Reports Third Quarter Earnings 53784 5MedCath Corporation Reports Third Quarter Earnings 53784 6MedCath Corporation Reports Third Quarter Earnings 53784 7MedCath Corporation Reports Third Quarter Earnings 53784 8MedCath Corporation Reports Third Quarter Earnings 53784 9MedCath Corporation Reports Third Quarter Earnings 53784 10MedCath Corporation Reports Third Quarter Earnings 53784 11MedCath Corporation Reports Third Quarter Earnings 53784 12MedCath Corporation Reports Third Quarter Earnings 53784 13MedCath Corporation Reports Third Quarter Earnings 53784 14MedCath Corporation Reports Third Quarter Earnings 53784 15MedCath Corporation Reports Third Quarter Earnings 53784 16Whats Lurking in Your Kitchen 3F 53781 1Whats Lurking in Your Kitchen 3F 53781 2Whats Lurking in Your Kitchen 3F 53781 3Whats Lurking in Your Kitchen 3F 53781 4
...t management efforts intended to assist migrations... consequences for fish populations. Juveniles that...ability to migrate back to their breeding grounds,...ons in the wild. , Transportation programs have ...e survival of fish that hatch in rivers but migrat...
...mber 25, 2008, the Obesity Institute at Children...any disciplines to share ideas, failures and succe...ervention strategies to fight childhood obesity, b... Through the Obesity Institute, Children,s Nationa...isciplinary approach that draws upon our experts f...
...re looking for bonefish from Miami down to the Mar...rom, and that is down slightly from the average of...ation among those who are counting, researchers sp...ol of Marine and Atmospheric Science held the sixt...ion with the conservation group Bonefish & Tarpon ...
Other Biology News:Transporting juvenile salmon hinders adult migration 2Transporting juvenile salmon hinders adult migration 3Children's National convenes first childhood obesity symposium 2Children's National convenes first childhood obesity symposium 3Children's National convenes first childhood obesity symposium 4Bonefish census reveals population holding steady 2
(Date:11/6/2009)...re-FirstCall/ - Oncolytics Biotech Inc. (TSX:ONC, ... announced updated results from a Phase II study o...s metastatic to the lung in a poster presentation ...ety Meeting held in Miami Beach, Florida, from Nov...d "A Phase II Study of Intravenous REOLYSIN (Wild-...
(Date:11/5/2009)...rid . . . , Fuel economy ratings for the new 2...www.fueleconomy.gov web site, which Oak Ridge Nat....S. Department of Energy and the U.S. Environmenta...n the best fuel economy list are hybrid electrics,.... "This list proves that hybrids have gone mainstr...
(Date:11/5/2009)... DSM Pharmaceutical Products today ...e with Galenix, Saint Jean D,Illac, France, where ...turing partner for Galenix commercial products on ...rate on business development opportunities co-mark... the strength of Galenix in drug product developme...
(Date:11/5/2009)...ay, November 5, 2009 at 4:30 p.m. Eastern Time ,...irstCall/ - OncoGenex Pharmaceuticals, Inc. ("Onco...ported unaudited financial results for the third q...d reviewed the Company,s highlights for the third ...results reflect the operations of OncoGenex Techno...
Breaking Biology Technology:Oncolytics Biotech(R) Inc. Collaborators Present Positive Phase II Sarcoma Trial Results at CTOS Annual Meeting 2Oncolytics Biotech(R) Inc. Collaborators Present Positive Phase II Sarcoma Trial Results at CTOS Annual Meeting 3November 2009 story tips from the US Department of Energy's Oak Ridge National Laboratory 2November 2009 story tips from the US Department of Energy's Oak Ridge National Laboratory 3DSM Pharmaceutical Products Forms Manufacturing Alliance With Galenix 2DSM Pharmaceutical Products Forms Manufacturing Alliance With Galenix 3OncoGenex Reports Third Quarter 2009 Financial Results 2OncoGenex Reports Third Quarter 2009 Financial Results 3OncoGenex Reports Third Quarter 2009 Financial Results 4OncoGenex Reports Third Quarter 2009 Financial Results 5OncoGenex Reports Third Quarter 2009 Financial Results 6OncoGenex Reports Third Quarter 2009 Financial Results 7OncoGenex Reports Third Quarter 2009 Financial Results 8
...is. - Cray Inc. , the Seattle-based supercompute... center here, has been awarded a $250 million agre...earch Projects Agency to develop what the company...er, the agreement,s impact on Cray,s Chippewa Fall...ch extends Cray,s part in DARPA,s High Productivit...
...- It,s not every day that Wisconsin has a chance t...more than 30 years since the National Wildlife He...y 100 years since the University of Wisconsin wa...e site for the National Forest Products Laborator...rld,s knowledge of wildlife diseases and forests -...
...he Wisconsin Innovation Network,s Centergy Chapte...ed economic development resource - state colleges ...d at the Wausau Business Development Center, busin... Wisconsin will have an opportunity to learn how t...he benefit of their organizations. , ,"There are h...
Other Biology Technology:Cray signs $250M deal to develop supercomputer 2National Bio and Agro Defense fits Wisconsin 2National Bio and Agro Defense fits Wisconsin 3National Bio and Agro Defense fits Wisconsin 4
Mouse Anti-Human gamma Glutamyl Transferase (gammaGT) Monoclonal Antibody, Unconjugated from AnaSpec
...to Cholesterol Oxidase Immunogen Cholesterol Oxi...ross-reacts with bacteria. Not yet tested in other...dases exist as both type I and type II oxidases an...ition, they are important as clinical reagents, po...
Goat Anti-XAGE1 Polyclonal Antibody, Unconjugated from Abcam
Mouse Anti-MDMA Monoclonal Antibody, Unconjugated, Clone 3G8 from ProSci, Inc
Biology Products: